Your browser doesn't support javascript.
loading
Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors.
Soldevilla, Mario M; Villanueva, Helena; Martinez-Velez, Naiara; Meraviglia-Crivelli, Daniel; Alonso, Marta M; Cebollero, Javier; Menon, Ashwathi P; Puigdelloses, Montserrat; Pastor, Fernando.
Afiliação
  • Soldevilla MM; Molecular Therapeutics Program, Center for Applied Medical Research, CIMA, University of Navarra, Pamplona, Spain.
  • Villanueva H; Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Martinez-Velez N; Molecular Therapeutics Program, Center for Applied Medical Research, CIMA, University of Navarra, Pamplona, Spain.
  • Meraviglia-Crivelli D; Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Alonso MM; Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Cebollero J; Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Menon AP; Department of Pediatrics, University Hospital of Navarra, Pamplona, Spain.
  • Puigdelloses M; Molecular Therapeutics Program, Center for Applied Medical Research, CIMA, University of Navarra, Pamplona, Spain.
  • Pastor F; Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain.
Oncoimmunology ; 7(8): e1450711, 2018.
Article em En | MEDLINE | ID: mdl-30221041

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article